Skip to content

E-cigarettes, Nicotine Inhaler, and Blood Vessel Function

The Effects of Electronic Cigarettes on Endothelial Function and Oxidative Stress

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03072628
Enrollment
148
Registered
2017-03-07
Start date
2017-01-11
Completion date
2022-12-01
Last updated
2023-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nicotine Dependence

Keywords

nicotine, sympathetic nerve activity, oxidative stress

Brief summary

Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity

Detailed description

Participants will have an acute exposure on 4 occasions1) e-cigarette with nicotine, 2) e-cigarette without nicotine, 3) nicotine inhaler, 4) sham control and undergo ECG recording for heart rate variability, endothelial function measurement using ultrasound (FMD) and blood tests for oxidative stress markers.

Interventions

OTHERe-cig with nicotine

use an e-cig with nicotine for 30 minutes

OTHERe-cig without nicotine

use an e-cig without nicotine for 30 minutes

use a nicotine inhaler for 30 minutes

OTHERsham control

use an empty e-cigarette for 30 minutes

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy

Exclusion criteria

* Cardiac disease * Respiratory disease * Diabetes mellitus

Design outcomes

Primary

MeasureTime frameDescription
Flow Mediated dilatation (FMD)10 minutes after exposureFMD is a measure of endothelial function
Heart rate variability (HRV)10 minutes after exposureHRV is a measure of cardiac sympathetic tone

Secondary

MeasureTime frameDescription
Paraoxonase (PON)~30 minutes after exposurePON is a measure of oxidative stress

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026